Archive: 15/11/2017
Mepsevii approved for rare enzyme disorder
(HealthDay)—Mepsevii (vestronidase alfa-vjbk) has been approved by the U.S. Food and Drug Administration to treat a rare, genetic disorder called mucopolysaccharidosis type VII, sometimes called Sly syndrome.
Nov 15, 2017